527 related articles for article (PubMed ID: 19390321)
1. Adrenal incidentalomas and subclinical Cushing's syndrome: diagnosis and treatment.
Mazzuco TL; Bourdeau I; Lacroix A
Curr Opin Endocrinol Diabetes Obes; 2009 Jun; 16(3):203-10. PubMed ID: 19390321
[TBL] [Abstract][Full Text] [Related]
2. Hormonal activity of adrenal incidentalomas: results from a long-term follow-up study.
Vassilatou E; Vryonidou A; Michalopoulou S; Manolis J; Caratzas J; Phenekos C; Tzavara I
Clin Endocrinol (Oxf); 2009 May; 70(5):674-9. PubMed ID: 19067718
[TBL] [Abstract][Full Text] [Related]
3. [Retrospective hormonal analysis of incidentally discovered and operated adrenal tumors for subclinical Cushing's syndrome].
Przybylik-Mazurek E; Buziak-Bereza M; Fedorowicz A; Kuźniarz-Rymarz S; Stochmal E; Hubalewska-Dydejczyk A
Przegl Lek; 2010; 67(12):1270-5. PubMed ID: 21591352
[TBL] [Abstract][Full Text] [Related]
4. Cardiovascular events and mortality in patients with adrenal incidentalomas that are either non-secreting or associated with intermediate phenotype or subclinical Cushing's syndrome: a 15-year retrospective study.
Di Dalmazi G; Vicennati V; Garelli S; Casadio E; Rinaldi E; Giampalma E; Mosconi C; Golfieri R; Paccapelo A; Pagotto U; Pasquali R
Lancet Diabetes Endocrinol; 2014 May; 2(5):396-405. PubMed ID: 24795253
[TBL] [Abstract][Full Text] [Related]
5. Subclinical Cushing's syndrome in adrenal incidentalomas.
Sippel RS; Chen H
Surg Clin North Am; 2004 Jun; 84(3):875-85. PubMed ID: 15145240
[TBL] [Abstract][Full Text] [Related]
6. Subclinical Cushing's syndrome due to adrenal myelolipoma.
Boronat M; Moreno A; Ramón y Cajal S; Pineda E; Lucas T; Estrada J
Arch Pathol Lab Med; 1997 Jul; 121(7):735-7. PubMed ID: 9240911
[TBL] [Abstract][Full Text] [Related]
7. Aberrant adrenal sensitivity to multiple ligands in unilateral incidentaloma with subclinical autonomous cortisol hypersecretion: a prospective clinical study.
Reznik Y; Lefebvre H; Rohmer V; Charbonnel B; Tabarin A; Rodien P; Lecomte P; Bardet S; Coffin C; Mahoudeau J;
Clin Endocrinol (Oxf); 2004 Sep; 61(3):311-9. PubMed ID: 15355446
[TBL] [Abstract][Full Text] [Related]
8. Clinicopathological correlates of adrenal Cushing's syndrome.
Duan K; Gomez Hernandez K; Mete O
J Clin Pathol; 2015 Mar; 68(3):175-86. PubMed ID: 25425660
[TBL] [Abstract][Full Text] [Related]
9. Adrenocorticotropic hormone-independent Cushing's syndrome.
Bourdeau I; Lampron A; Costa MH; Tadjine M; Lacroix A
Curr Opin Endocrinol Diabetes Obes; 2007 Jun; 14(3):219-25. PubMed ID: 17940443
[TBL] [Abstract][Full Text] [Related]
10. [Subclinical Cushing's syndrome:analysis of diagnosis and surgical effect].
Feng C; Li HZ; Xiao H; Yan WG; Li YQ; Xu WF
Zhonghua Wai Ke Za Zhi; 2007 Dec; 45(24):1691-3. PubMed ID: 18476528
[TBL] [Abstract][Full Text] [Related]
11. [Clinical aspect of adrenal incidentaloma].
Miyamori I
Nihon Rinsho; 2004 May; 62(5):925-8. PubMed ID: 15148820
[TBL] [Abstract][Full Text] [Related]
12. Late-night salivary cortisol for diagnosis of overt and subclinical Cushing's syndrome in hospitalized and ambulatory patients.
Nunes ML; Vattaut S; Corcuff JB; Rault A; Loiseau H; Gatta B; Valli N; Letenneur L; Tabarin A
J Clin Endocrinol Metab; 2009 Feb; 94(2):456-62. PubMed ID: 19001518
[TBL] [Abstract][Full Text] [Related]
13. Myelolipomatous adrenal masses causing Cushing's syndrome.
Lamas C; López LM; Lozano E; Atienzar M; Ruiz-Mondéjar R; Alfaro JJ; Botella F
Exp Clin Endocrinol Diabetes; 2009 Sep; 117(8):440-5. PubMed ID: 19373749
[TBL] [Abstract][Full Text] [Related]
14. Subclinical Cushing's syndrome in adrenal incidentalomas.
Terzolo M; Bovio S; Reimondo G; Pia A; Osella G; Borretta G; Angeli A
Endocrinol Metab Clin North Am; 2005 Jun; 34(2):423-39, x. PubMed ID: 15850851
[TBL] [Abstract][Full Text] [Related]
15. [Problems of cortisol assay: confusion in the diagnosis of preclinical Cushing's syndorme].
Odagiri E; Naruse M; Tanabe A; Ohmura M; Oki T; Katabami T; Saitoh J; Nishika T; Shibata H; Doi M; Hirata Y
Rinsho Byori; 2007 Jun; 55(6):549-54. PubMed ID: 17657989
[TBL] [Abstract][Full Text] [Related]
16. Subclinical Cushing's syndrome.
Terzolo M; Reimondo G; Bovio S; Angeli A
Pituitary; 2004; 7(4):217-23. PubMed ID: 16132200
[TBL] [Abstract][Full Text] [Related]
17. [Subclinical Cushing's syndrome and preclinical Cushing's syndrome].
Tanaka I
Nihon Rinsho; 2006 May; Suppl 1():604-6. PubMed ID: 16776227
[No Abstract] [Full Text] [Related]
18. Cushing's syndrome of nonpituitary causes.
Carroll TB; Findling JW
Curr Opin Endocrinol Diabetes Obes; 2009 Aug; 16(4):308-15. PubMed ID: 19491665
[TBL] [Abstract][Full Text] [Related]
19. Update on subclinical Cushing's syndrome.
Nieman LK
Curr Opin Endocrinol Diabetes Obes; 2015 Jun; 22(3):180-4. PubMed ID: 25887388
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of GH reserve in patients with adrenal incidentalomas and biochemical evidence of subclinical autonomous glucocorticoid hypersecretion.
Tzanela M; Zianni D; Stylianidou Ch; Karavitaki N; Tsagarakis S; Thalassinos NC
Clin Endocrinol (Oxf); 2005 May; 62(5):597-602. PubMed ID: 15853831
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
